|
Inhibitor of Differentiation Proteins
|
D051796 |
[Inhibitor of differentiation proteins are negative regulators of BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS. They inhibit CELL DIFFERENTIATION and induce CELL PROLIFERATION by modulating different CELL CYCLE regulators.
] |
|
Inhibitor of Growth Protein 1
|
D000076023 |
[A nuclear protein and tumor suppressor that contains a C-terminal PHD ZINC FINGER. It is expressed in different isoforms in various tissues and interacts with TUMOR SUPPRESSOR PROTEIN P53 to negatively regulate cell growth. Reduced expression and chromosomal rearrangements of the ING1 gene are associated with different cancers including HEAD AND NECK NEOPLASMS.
] |
|
Inhibitory Concentration 50
|
D020128 |
[The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture.
] |
|
Inhibitory Postsynaptic Potentials
|
D053444 |
[The flow of ions into or out of cells that cause INHIBITORY POSTSYNAPTIC POTENTIALS.
, Hyperpolarization of membrane potentials at the SYNAPTIC MEMBRANES of target neurons during NEUROTRANSMISSION. They are local changes which diminish responsiveness to excitatory signals.
] |
|
Injection Site Reaction
|
D000075662 |
[Adverse reactions that occur initially at the site of injection or infusion. Milder type is confined to a local allergic flare reaction. A more severe reaction is caused by extravasation of VESICANTS from the blood vessel at the site of injection and can cause damage to the surrounding tissue. In tumor flare reaction symptoms involve well beyond the injection site such as an increase in the tumor size and tumor markers levels, bone pain, and HYPERCALCEMIA.
] |
|
Injection, Intratympanic
|
D000069555 |
[The administration of liquid substances into the TYMPANIC CAVITY with a hypodermic syringe.
] |
|
Injections
|
D007267 |
[Introduction of substances into the body using a needle and syringe.
] |
|
Injections, Epidural
|
D007268 |
[The injection of drugs, most often analgesics, into the spinal canal without puncturing the dura mater.
] |
|
Injections, Intra-Arterial
|
D007269 |
[Delivery of drugs into an artery.
] |
|
Injections, Intra-Articular
|
D007270 |
[Methods of delivering drugs into a joint space.
] |
|
Injections, Intradermal
|
D007271 |
[The forcing into the skin of liquid medication, nutrient, or other fluid through a hollow needle, piercing the top skin layer.
] |
|
Injections, Intralesional
|
D015552 |
[Injections introduced directly into localized lesions.
] |
|
Injections, Intralymphatic
|
D007272 |
[Injections into the lymph nodes or the lymphatic system.
] |
|
Injections, Intramuscular
|
D007273 |
[Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it.
] |
|
Injections, Intraocular
|
D056965 |
[The administration of substances into the eye with a hypodermic syringe.
] |
|
Injections, Intraperitoneal
|
D007274 |
[Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall.
] |
|
Injections, Intravenous
|
D007275 |
[Injections made into a vein for therapeutic or experimental purposes.
] |
|
Injections, Intraventricular
|
D007276 |
[Injections into the cerebral ventricles.
] |
|
Injections, Jet
|
D007277 |
[The injection of solutions into the skin by compressed air devices so that only the solution pierces the skin.
] |
|
Injections, Spinal
|
D007278 |
[Introduction of therapeutic agents into the spinal region using a needle and syringe.
] |
